H-SGFRK^ME-OH

Ref. 3D-PP47185

Informations sur le produit

• Nom: H-SGFRK^ME-OH

Description

Peptide H-SGFRK^ME-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SGFRK^ME-OH include the following: Advances in Redox Research Y Kato , A Higashiyama, E Takaoka, M Nishikawa - researchgate.nethttps://www.researchgate.net/profile/Yoji-Kato/publication/355270825_Food_phytochemicals_epigallocatechin_gallate_and_myricetin_covalently_bind_to_the_active_site_of_the_coronavirus_main_protease_in_vitro/links/616f8d37b148a924b800781e/Food-phytochemicals-epigallocatechin-gallate-and-myricetin-covalently-bind-to-the-active-site-of-the-coronavirus-main-protease-in-vitro.pdf?origin=journalDetail&_tp=eyJwYWdlIjoiam91cm5hbERldGFpbCJ9 Composition of Lipophilic Components of Rhododendron adamsii Rehd. Ether Extract and Activity against SARS-CoV-2 Main Protease TP Kukina, IA Elshin, OI Sal'nikova, PV Kolosov - Russian Journal of , 2023 - Springerhttps://link.springer.com/article/10.1134/S1068162023070828 Synthesis and Properties of New Conjugates of Isatin and Bicyclic Monoterpenes OI Yarovaya , DS Baev , KS Kovaleva, YV Gatilov - Russian Journal of , 2024 - Springerhttps://link.springer.com/article/10.1134/S1070363224010080 Usnic acid based thiazole-hydrazones as multi-targeting inhibitors of a wide spectrum of SARS-CoV-2 viruses OI Yarovaya , AS Filimonov, DS Baev - New Journal of , 2023 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2023/nj/d3nj03598k The Potential of Usnic-Acid-Based Thiazolo-Thiophenes as Inhibitors of the Main Protease of SARS-CoV-2 Viruses OI Yarovaya , AS Filimonov, DS Baev , SS Borisevich - Viruses, 2024 - mdpi.comhttps://www.mdpi.com/1999-4915/16/2/215 Rational design of a new class of protease inhibitors for the potential treatment of coronavirus diseases M Westberg , Y Su , X Zou , L Ning, B Hurst, B Tarbet - bioRxiv, 2020 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2020.09.15.275891.abstract Protocol for production and purification of SARS-CoV-2 3CLpro L Mazzei , R Greene-Cramer, K Bafna , A Jovanovic - STAR protocols, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2666166723002939 Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses L Brier, H Hassan , X Hanoulle , V Landry - European journal of , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0223523423001010 Hepatitis C Virus Drugs Simeprevir And Grazoprevir Synergize with Remdesivir to Suppress SARS-CoV2 Replication K Bafna , K White, H Balasubramanian - Available at SSRN , 2020 - papers.ssrn.comhttps://papers.ssrn.com/sol3/papers.cfm?abstract_id=3742249 Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture K Bafna , K White, B Harish , R Rosales , TA Ramelot - Cell reports, 2021 - cell.comhttps://www.cell.com/cell-reports/pdf/S2211-1247(21)00472-1.pdf Hepatitis C Virus drugs simeprevir and grazoprevir synergize with remdesivir to suppress SARS-CoV-2 replication in Cell Culture K Bafna , K White, B Harish , R Rosales , TA Ramelot - BioRxiv, 2020 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2020.12.13.422511.abstract A yeast-based system to study SARS-CoV-2 Mpro structure and to identify nirmatrelvir resistant mutations J Ou , EM Lewandowski, Y Hu , AA Lipinski - PLoS , 2023 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1011592 Triterpenic acid amides as potential inhibitors of the SARS-CoV-2 main protease DS Baev , ME Blokhin, VY Chirkova, SV Belenkaya - Molecules, 2022 - mdpi.comhttps://www.mdpi.com/1420-3049/28/1/303 Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease C Ma , MD Sacco , B Hurst, JA Townsend , Y Hu , T Szeto - Cell research, 2020 - nature.comhttps://www.nature.com/articles/s41422-020-0356-z Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays C Ma , H Tan , J Choza, Y Wang, J Wang - Acta Pharmaceutica Sinica B, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2211383521004299

• Marque: Biosynth